Neurocrine Biosciences, Inc.

NB3.F·Frankfurt·Healthcare
Compare
145.15+0.15 (+0.10%)today
As of Nov 5, 8:04 AM CET · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close145.00
Open145.15
Day range—
52-week range102.55160.50
Off day high0.00%
Off 52-week high−9.56%
Volume120
Avg. volume (3M)40.00
Market cap14.69B
EPS (TTM)5.80
Forward P/E37.60
P/E ratio (TTM)25.03
Dividend yield—
Beta (5Y)0.33
Shares outstanding101.22M
Short interest—
Earnings dateNov 2, 2026
Analyst target—
Profit margin18.98%

Against its peers

Compare in full ›
NB3.F ALKS SUVEN.BO 4119.TW SUPN AMLX
Market cap 14.69B 7.71B 63.96B 6.05B 1.64B 3.69B
P/E (TTM) 25.0 — — 99.2 — —
Forward P/E 37.6 25.4 23.5 9.0 6.3 -27.0
Price/book 4.3 4.1 21.8 1.1 -55.5 13.7
Dividend yield — — — 1.47% — —
1-year change +0.62% +44.85% +30.58% −9.43% −12.17% +135.96%
Today +0.10% +0.44% −0.14% −0.59% +0.21% +0.68%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 20 min.

Related companies

Compare ›

Also based in San Diego, California, then elsewhere in California.

Company Mkt cap Price Today
QUALCOMM IncorporatedQCOM · San Diego, CA 184.94B 173.19 +5.33%
Illumina, Inc.ILMN · San Diego, CA 34.25B 226.54 −4.90%
Realty Income CorporationO · San Diego, CA 56.04B 59.22 +2.99%
DexCom, Inc.DXCM · San Diego, CA 33.00B 88.48 +6.64%
SempraSRE · San Diego, CA 54.21B 82.90 −2.88%
ResMed Inc.RMD · San Diego, CA 33.83B 240.51 +5.91%
LPL Financial Holdings Inc.LPLA · San Diego, CAOdds 24.25B 311.48 +4.64%
Halozyme Therapeutics, Inc.HALO · San Diego, CA 14.79B 130.34 +1.34%

What visitors to Neurocrine Biosciences's page also look at.

Company Mkt cap Price Today
VERTEX PHARMACEUTICALS INC.VX1.F 122.76B 484.35 −0.51%
Incyte Corp.ICY.F 22.13B 108.55 +4.83%
Halozyme Therapeutics Inc.RV7.F 13.05B 115.00 +1.23%
Sarepta Therapeutics Inc.AB3A.F 1.76B 16.62 +2.34%
Alnylam Pharmaceuticals IncDUL.F 19.44B 145.15 +0.07%

From the 4SEARCH.business instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All NB3.F news ›
Neurocrine Biosciences··2 outletsPositive

Neurocrine Biosciences Reports Third-Quarter 2026 Financial Results

Total Third-Quarter 2026 Revenue Grew 41% Year-Over-Year to $1.1 Billion INGREZZA® (valbenazine) 2026 Net Sales Guidance Raised to $2.9 to $2.925 Billion SAN DIEGO, Nov. 2, 2026 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX)…

NBIXCNSPASPE
More from 1 other outlet

From the 4Search news index, newest first.

In the news

18mentions in 30 days
18with it in the headline
Positivesentiment

Mentioned with

Neurocrine Biosciences, Inc.11Biogen6Eli Lilly5TD Cowen5Goldman Sachs4Neurocrine4Nvidia4Vertex Pharmaceuticals4

People in the coverage

Mitch Edgeman15Danessa Lincoln9Kim Johansen7David W. Boyer6Biopharma5Eiry Roberts5

Themes

Healthcare14Earnings10Nbix10EPS6SEC Filings6Stock Analysis6Consensus5Ratings5

Most coverage from

  1. marketscreener.com5
  2. defenseworld.net2
  3. seekingalpha.com2
  4. fool.com1
  5. insidermonkey.com1

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 18 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance